Pathstone Holdings LLC Reduces Position in Addus HomeCare Co. (NASDAQ:ADUS)

Pathstone Holdings LLC reduced its holdings in Addus HomeCare Co. (NASDAQ:ADUS) by 1.0% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 13,061 shares of the company’s stock after selling 136 shares during the period. Pathstone Holdings LLC’s holdings in Addus HomeCare were worth $1,738,000 at the end of the most recent quarter.

Other large investors have also made changes to their positions in the company. UMB Bank n.a. boosted its holdings in shares of Addus HomeCare by 64.2% in the 2nd quarter. UMB Bank n.a. now owns 225 shares of the company’s stock valued at $26,000 after acquiring an additional 88 shares during the last quarter. Quest Partners LLC purchased a new stake in shares of Addus HomeCare in the 2nd quarter valued at $31,000. Farther Finance Advisors LLC boosted its holdings in shares of Addus HomeCare by 9,150.0% in the 3rd quarter. Farther Finance Advisors LLC now owns 370 shares of the company’s stock valued at $49,000 after acquiring an additional 366 shares during the last quarter. Innealta Capital LLC purchased a new stake in shares of Addus HomeCare in the 2nd quarter valued at $44,000. Finally, Sandia Investment Management LP purchased a new stake in shares of Addus HomeCare in the 2nd quarter valued at $58,000. 95.35% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on the stock. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $136.00 price objective on shares of Addus HomeCare in a report on Thursday, November 14th. Oppenheimer increased their price target on shares of Addus HomeCare from $140.00 to $145.00 and gave the stock an “outperform” rating in a report on Monday, September 23rd. Stephens increased their price target on shares of Addus HomeCare from $143.00 to $145.00 and gave the stock an “overweight” rating in a report on Wednesday, November 6th. TD Cowen increased their price target on shares of Addus HomeCare from $128.00 to $137.00 and gave the stock a “buy” rating in a report on Thursday, August 8th. Finally, KeyCorp assumed coverage on shares of Addus HomeCare in a report on Friday, October 11th. They set an “overweight” rating and a $150.00 price target on the stock. One research analyst has rated the stock with a sell rating, eight have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, Addus HomeCare currently has an average rating of “Moderate Buy” and a consensus price target of $131.63.

Addus HomeCare Stock Performance

NASDAQ:ADUS opened at $121.29 on Thursday. The company has a fifty day moving average of $127.91 and a two-hundred day moving average of $123.51. The stock has a market capitalization of $2.20 billion, a PE ratio of 28.47, a P/E/G ratio of 2.15 and a beta of 1.04. Addus HomeCare Co. has a fifty-two week low of $85.43 and a fifty-two week high of $136.12.

Addus HomeCare (NASDAQ:ADUS) last posted its quarterly earnings data on Monday, November 4th. The company reported $1.30 earnings per share for the quarter, topping analysts’ consensus estimates of $1.28 by $0.02. The company had revenue of $289.80 million during the quarter, compared to analysts’ expectations of $289.42 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The firm’s revenue for the quarter was up 7.1% on a year-over-year basis. During the same period in the prior year, the business posted $1.03 earnings per share. Research analysts forecast that Addus HomeCare Co. will post 4.58 earnings per share for the current year.

Insiders Place Their Bets

In other news, Director Esteban Lopez sold 500 shares of the stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $127.50, for a total value of $63,750.00. Following the completion of the sale, the director now directly owns 3,366 shares in the company, valued at $429,165. This represents a 12.93 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO R Dirk Allison sold 12,500 shares of the stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $123.16, for a total transaction of $1,539,500.00. Following the completion of the sale, the chief executive officer now owns 141,897 shares of the company’s stock, valued at $17,476,034.52. This trade represents a 8.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 13,500 shares of company stock worth $1,668,265. Company insiders own 4.60% of the company’s stock.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.